Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulae: Routine vs On-Demand Nebulization in ICU
NCT02159196Completed
- Sponsor
- University of Amsterdam
- Start
- Jul 2014
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of acetylcysteine and salbutamol in respiratory failure (2 arms), sponsored by University of Amsterdam. Primary endpoint: Number of ventilator-free days at day 28. Started Jul 2014; status: completed.
02
Drugs
acetylcysteinesalbutamol
03
Conditions
respiratory failure
Beyond the preview
Go deeper on NCT02159196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02159196.